Stearoyl-CoA desaturase in development and disease

Area of Science:

• Biochemistry
• Molecular Biology
• Genomics

Background:

• Fatty acid desaturation is an enzymatic process introducing double bonds, increasing structural and functional complexity.
• Desaturases are ubiquitous in eukaryotes and bacteria, with membrane-bound forms being dominant.
• Stearoyl-CoA desaturases (SCDs) are the predominant members of the First Desaturase subfamily, catalyzing the rate-limiting step in monounsaturated fatty acid synthesis.

Purpose of the Study:

• To review the latest findings on the roles of Stearoyl-CoA desaturases (SCDs).
• To explore both expected and unanticipated functions of SCD in development, metabolism, and disease.
• To focus on the involvement of SCD in cancer and central nervous system disorders.

Main Methods:

• Bioinformatic analysis of 56 eukaryotic genomes identified 275 desaturase homologs.
• Review of existing literature on SCD localization, function, and regulation.
• Synthesis of current knowledge on SCD's impact on cellular processes and disease states.

Main Results:

• SCD enzymes are crucial for converting saturated fatty acids (SFAs) to monounsaturated fatty acids (MUFAs) at the endoplasmic reticulum.
• MUFAs produced by SCD are essential for synthesizing cell membrane components, influencing membrane fluidity, organelle function, and signal transduction.
• SCD activity is a critical regulator of the SFA to MUFA ratio, affecting cell function, growth, and survival.

Conclusions:

• SCD plays a vital role in cellular homeostasis and is implicated in various physiological and pathological processes.
• Understanding SCD's multifaceted roles is crucial for developing therapeutic strategies targeting metabolic and developmental disorders, including cancer and CNS diseases.
• Further research is warranted to fully elucidate the complex mechanisms underlying SCD's functions and its therapeutic potential.